3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
66
Lymphoma, Follicular
21
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Mantle-Cell
10
Lymphoma
10
Recurrence
7
Lymphoma, B-Cell, Marginal Zone
7
Neoplasms, Plasma Cell
6
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Smoldering Multiple Myeloma
3
Neoplasms
3
Neuroblastoma
2
Neoplasm, Residual
2
Myelodysplastic Syndromes
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Hematologic Diseases
2
Burkitt Lymphoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Interventions
X-Rays
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Vincristine
5
Nuclear Medicine Department, Hospital
5
Biopsy
5
Doxorubicin
4
Etoposide
3
Dactinomycin
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
Radiotherapy, Conformal
2
Radiotherapy
2
Radiation
2
LY3023414
2
Irinotecan
2
talazoparib
1
selinexor
1
pembrolizumab
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Lenalidomide
×
90 days
×
Clear all
No trials found.